BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35568099)

  • 1. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
    Chi J; Liu Y; Yang L; Yang J
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
    Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
    Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
    Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
    Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
    Li Y; Li R; Qin H; He H; Li S
    Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Zou C
    J Immunol Res; 2021; 2021():5524231. PubMed ID: 34414241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
    Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Periodontitis Promotes the Progression of Oral Squamous Cell Carcinoma by Inducing Macrophage M2 Polarization].
    Li J; Wei W; Tang BY; Li Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):83-90. PubMed ID: 36647648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
    Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
    Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
    Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
    Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma.
    Xiao M; Zhang J; Chen W; Chen W
    J Exp Clin Cancer Res; 2018 Jul; 37(1):143. PubMed ID: 29986759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of RhoC induces macrophage M1 polarization to inhibit migration and invasion in colon cancer via regulating the PTEN/FOXO1 pathway.
    Yang B; Wang L; Tian Z
    Int J Exp Pathol; 2023 Feb; 104(1):33-42. PubMed ID: 36576072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
    Lin Y; Qi Y; Jiang M; Huang W; Li B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
    Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
    Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.
    You Y; Tian Z; Du Z; Wu K; Xu G; Dai M; Wang Y; Xiao M
    J Exp Clin Cancer Res; 2022 Jan; 41(1):10. PubMed ID: 34991668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
    Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
    Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.